documents: FDA-2024-E-3572-0007
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-E-3572-0007 | FDA | FDA-2024-E-3572 | Determination of Regulatory Review Period for Purposes of Patent Extension; TEVIMBRA | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:52:55 | 2026-03851 | 1 | 0 | 09000064b91deb48 |